Atopic dermatitis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (13 intermediate revisions by 4 users not shown) | |||
| Line 2: | Line 2: | ||
{{Atopic dermatitis}} | {{Atopic dermatitis}} | ||
{{CMG}} | {{CMG}} {{AE}}{{S.S}} | ||
== Overview == | ==Overview== | ||
Secondary prevention applies to the [[patients]] with diagnosed atopic dermatitis. Its main goal is to reduce the severity of presentation of [[skin lesions]] as well as the use of medical therapy in treating atopic dermatitis. | |||
==Secondary Prevention = | ==Secondary Prevention== | ||
Secondary prevention involves protecting and restoring the epidermal skin barrier function including:<ref name="pmid26755903">{{cite journal |vauthors=Oszukowska M, Michalak I, Gutfreund K, Bienias W, Matych M, Szewczyk A, Kaszuba A |title=Role of primary and secondary prevention in atopic dermatitis |journal=Postepy Dermatol Alergol |volume=32 |issue=6 |pages=409–20 |date=December 2015 |pmid=26755903 |pmc=4697018 |doi=10.5114/pdia.2014.44017 |url=}}</ref><ref name="pmid19494826">{{cite journal |vauthors=Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ |title=Epidermal barrier dysfunction in atopic dermatitis |journal=J. Invest. Dermatol. |volume=129 |issue=8 |pages=1892–908 |date=August 2009 |pmid=19494826 |doi=10.1038/jid.2009.133 |url=}}</ref><ref name="pmid21068735">{{cite journal |vauthors=Cho JS, Xuan C, Miller LS |title=Lucky number seven: RNase 7 can prevent Staphylococcus aureus skin colonization |journal=J. Invest. Dermatol. |volume=130 |issue=12 |pages=2703–6 |date=December 2010 |pmid=21068735 |doi=10.1038/jid.2010.294 |url=}}</ref><ref name="pmid18606083">{{cite journal |vauthors=Arndt J, Smith N, Tausk F |title=Stress and atopic dermatitis |journal=Curr Allergy Asthma Rep |volume=8 |issue=4 |pages=312–7 |date=July 2008 |pmid=18606083 |doi= |url=}}</ref><ref name="StänderRopper2021">{{cite journal|last1=Ständer|first1=Sonja|last2=Ropper|first2=Allan H.|title=Atopic Dermatitis|journal=New England Journal of Medicine|volume=384|issue=12|year=2021|pages=1136–1143|issn=0028-4793|doi=10.1056/NEJMra2023911}}</ref> | |||
*[[Patients]] should: | |||
*Abstain from using soap, cosmetics, dyes, fragrances and detergents. | |||
*Wash new clothes before wearing them. | |||
*Keep air temperature around 18–22°C. | |||
*Avoid frequent and sudden climate changes. | |||
*Use air humidifiers in winters. | |||
*Avoid excessive exposure to UV radiations and use SPF sunscreens. | |||
*Apply of emollients every 6 hours | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
<br /> | |||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Latest revision as of 03:10, 26 April 2021
|
Atopic dermatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Atopic dermatitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Atopic dermatitis secondary prevention |
|
Risk calculators and risk factors forAtopic dermatitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shalinder Singh, M.B.B.S.[2]
Overview
Secondary prevention applies to the patients with diagnosed atopic dermatitis. Its main goal is to reduce the severity of presentation of skin lesions as well as the use of medical therapy in treating atopic dermatitis.
Secondary Prevention
Secondary prevention involves protecting and restoring the epidermal skin barrier function including:[1][2][3][4][5]
- Patients should:
- Abstain from using soap, cosmetics, dyes, fragrances and detergents.
- Wash new clothes before wearing them.
- Keep air temperature around 18–22°C.
- Avoid frequent and sudden climate changes.
- Use air humidifiers in winters.
- Avoid excessive exposure to UV radiations and use SPF sunscreens.
- Apply of emollients every 6 hours
References
- ↑ Oszukowska M, Michalak I, Gutfreund K, Bienias W, Matych M, Szewczyk A, Kaszuba A (December 2015). "Role of primary and secondary prevention in atopic dermatitis". Postepy Dermatol Alergol. 32 (6): 409–20. doi:10.5114/pdia.2014.44017. PMC 4697018. PMID 26755903.
- ↑ Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, Guy RH, Macgowan AL, Tazi-Ahnini R, Ward SJ (August 2009). "Epidermal barrier dysfunction in atopic dermatitis". J. Invest. Dermatol. 129 (8): 1892–908. doi:10.1038/jid.2009.133. PMID 19494826.
- ↑ Cho JS, Xuan C, Miller LS (December 2010). "Lucky number seven: RNase 7 can prevent Staphylococcus aureus skin colonization". J. Invest. Dermatol. 130 (12): 2703–6. doi:10.1038/jid.2010.294. PMID 21068735.
- ↑ Arndt J, Smith N, Tausk F (July 2008). "Stress and atopic dermatitis". Curr Allergy Asthma Rep. 8 (4): 312–7. PMID 18606083.
- ↑ Ständer, Sonja; Ropper, Allan H. (2021). "Atopic Dermatitis". New England Journal of Medicine. 384 (12): 1136–1143. doi:10.1056/NEJMra2023911. ISSN 0028-4793.